Judith van Deutekom

Dr. van Deutekom is the scientific co-founder of VICO Therapeutics and has an extensive track record in RNA modulating therapeutics. She has served as VP of Drug Discovery at BioMarin Pharmaceutical Inc. and as Site Head of BioMarin Nederland from 2015-2019 and was CSO at Prosensa Therapeutics B.V. from 2007-2015.

She was one of the pioneers of the application of antisense oligonucleotides and the exon-skipping technology for Duchenne Muscular Dystrophy (DMD) and has an extensive track record in the (pre)clinical development of antisense oligonucleotides for rare neuromuscular and neurodegenerative diseases since 1998. She is (co)inventor of more than 15 patent families in that field.